Liver Transplantation for HCC: Indication Criteria and Perioperative Risk Factors for Survival
Contents
Chair(s)
Giuliano Ramadori, MD
Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany;
Executive Chief Editor of Hepatoma Research.
Umberto Cillo, MD, PhD
Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy;
Professor of General Surgery from the University of Padova;
Director, University of Padova.
Speaker(s)
Salvatore Gruttadauria, MD, FACS, PhD
Chairman, Department for the Treatment and the Study of Abdominal Diseases and Abdominal Transplantation, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), University of Pittsburgh Medical Center (UPMC), Palermo, Italy;
Associate Chief Editor of Hepatoma Research.
Duilio Pagano, MD, PhD
Paolo De Simone, MD, PhD
Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy.
Andrea Schlegel, MD, MBA
General Surgeon in Cleveland, Cleveland Clinic.
Umberto Cillo, MD, PhD
Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy;
Professor of General Surgery from the University of Padova;
Martina Gambato
George Tsoulfas
Pierluigi Toniutto
Riccardo De Carlis
| Time (Berlin, GMT+2) | Speakers | Topics |
| 15:00 - 15:05 | Chairs (Giuliano Ramadori, Umberto Cillo) | Welcome Remarks |
| 15:05 - 15:25 | Paolo De Simone | / |
| 15:25 - 15:45 | Duilio Pagano | Impact of laparoscopic resection for access to the waiting list for liver transplantation: entry and dropout flows' analysis |
| 15:45 - 16:05 | Martina Gambato | Immunotherapy for HCC in liver transplant setting |
| 16:05 - 16:25 | Riccardo De Carlis | Downstaging for HCC in liver transplantation |
| 16:25 - 16:40 | / | Discussion Part 1 |
| 16:40 - 16:50 | Chair (Giuliano Ramadori) | Introduction for the Journal |
| 16:50 - 17:10 | Umberto Cillo | Therapeutic hierarchy of HCC |
| 17:10 - 17:30 | George Tsoulfas | The role of technological innovation in the management of HCC with liver transplantation |
| 17:30 - 17:50 | Andrea Schlegel | The impact of donor and graft quality on cancer recurrence after liver transplantation |
| 17:50 - 18:15 | Pierluigi Toniutto | Indications to liver transplantation for HCC: the transplant hepatologist point of view |
| 18:15 - 18:30 | / | Discussion Part 2 |
| 18:30 - 18:35 | Chairs (Giuliano Ramadori, Umberto Cillo) | Concluding Remarks |
Moments
Presentation
Paolo De Simone, Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy.
Topic: Liver transplantation for HCC: Indication criteria and perioperative risk factors for survival
Andrea Schlegel, General Surgeon in Cleveland, Cleveland Clinic.
Topic: The impact of donor and graft quality on cancer recurrence after liver transplantation
Riccardo De Carlis, HPB and Transplant Surgeon at Niguarda Hospital, Milan, Italy.
Topic: Downstaging for HCC in liver transplantation
Duilio Pagano, Mediterranean Institute for Transplantation and Highly Specialized Therapies (ISMETT)Palermo, Italy.
Topic: Impact of laparoscopic resection for access to the waiting list for liver transplantation: entry and dropout flows' analysis
Martina Gambato, Gastroenterologist and Transplant Hepatologist, Padua University Hospital, Padua, Italy.
Topic: Immunotherapy for HCC in liver transplant setting
Umberto Cillo, Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy.
Topic: Therapeutic hierarchy of HCC
